Published time: 14 April 2020
Authors: Benjamin N. Rome, M.D., and Jerry Avorn, M.D.
Keywords: coronavirus, COVID-19, drugs, medicine
The search for a treatment for Covid-19 is testing our country’s ability to quickly develop, test, and deploy medications, presenting both opportunities and challenges to our drug-assessment apparatus. Several aspects of the U.S. response raise serious concerns, highlighting how the processes for evaluating and approving drugs can go awry during a public health crisis.
Drug Evaluation during the Covid-19 Pandemic